Send to

Choose Destination
Exp Oncol. 2006 Jun;28(2):163-5.

Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine.

Author information

Department of Biological Sciences, Middle East Technical University, Ankara, Turkey.



The goals of the study were to reveal the involvement of P-glycoprotein (P-gp), the product of multidrug resistance 1 gene (MDR1) in cellular resistance to vincristine (VCR) and investigate cross-resistance against cytosine arabinoside (Ara-C) in HL60 and HL60/VCR cell lines.


HL60 cells (human acute myeloid leukemia cell line) were cultured on medium with 1-50 nM of VCR for 4-6 weeks, and VCR resistant cells (HL60/VCR) were selected. The viability of cells was assessed by MTT assay and the expression of MDR1 gene was detected by RT-PCR.


No expression of MDR1 gene was revealed in HL60 cells, but MDR1 started to be expressed after incubation of cells with 2 nM of VCR and its expression level elevates with increase of agent concentration. MTT test has shown that HL-60/VCR cells were 75-fold more resistant to VCR and 42-fold higher resistant to cytosine arabinoside (Ara-C) compared to sensitive HL60 cells.


Aquired resistance to VCR and cross-resistance to Ara-C correlates with MDR1 gene expression in vitro.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center